The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
So that tells us that that massive amount of insulin is enough to reactivate PI3 kinase in the liver and muscle. And so it's not going around PI3 kinase. It's just reactivating it in spite of the presence of the drug. Because you can't develop a complete inhibitor for physiologic reasons.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.